Letermovir tablets (Letermovir) price and market reference cost analysis

Letermovir tablets (Letermovir) is an antiviral drug mainly used to prevent cytomegalovirus (CMV) infection in patients with hematopoietic stem cell transplantation (HSCT). In the Chinese market, letermovir is already on the market and available in tablet and injection forms. Both forms have been included in medical insurance, which eases the financial burden on patients during clinical use and provides effective prevention methods for patients at high risk of CMV infection after HSCT.

In the domestic market, letermovir tablets are relatively expensive, with each box selling for tens of thousands of yuan. The specific cost will vary in different regions and pharmacies. Tablets are usually used for oral maintenance and are convenient for long-term use and home management, while injections cost about five to six hundred yuan per box and are mainly used for hospitalized patients or special situations where oral administration is not possible. Due to the coverage of medical insurance reimbursement, the patient's actual out-of-pocket expense may be lower than the retail price, but it still needs to be calculated specifically according to local policies and hospital settlement methods.

Generic drugs of Letermovir are also available in overseas markets. For example, a box of tablets produced by Lucius in Laos sells for about 2,000 yuan, which is more economical than the original drug. The existence of overseas generic drugs provides a reference for domestically obtaining drugs through cross-border medical treatment or special import channels, but attention must be paid to the source and quality supervision of drugs to ensure drug safety.

Overall, letermovir has become an important drug for HSCTpatientsCMV prevention in China, and its tablet and injection forms meet different clinical needs. Although tablet prices are on the high side, medical insurance coverage and reference prices for overseas generic drugs provide patients with more choices. During clinical use, the dosage form and medication regimen should be reasonably selected based on the patient's economic status, administration method, and treatment cycle to maximize the preventive effect.

Keyword tags: letermovir,CMVPrevention, price, medical insurance, overseas generic drugs

Reference materials:https://www.mayoclinic.org/drugs-supplements/letermovir-oral-route/description/drg-20406647